Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Pfizer bets on biotech flu vaccine in BioNTech alliance

Pfizer will pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest major pharma company to bank on a promising new genetic approach.

Read More »

Express Scripts staking out million dollar gene therapies

Express Scripts Holding Co. built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now the pharmacy benefit manager is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

Read More »

Gilead Sciences Announces Executive Promotions

Gilead Sciences Inc. announced that Gregg Alton was appointed Chief Patient Officer, a newly created role that will facilitate access to the company’s medicines and increase focus on reaching patients. The company also announced that Diana Brainard, MD, was promoted to Senior Vice President, HIV and Emerging Viral Infections, and that Andrew Cheng, MD, PhD, Chief Medical Officer, decided to leave Gilead to pursue another opportunity.

Read More »

New York sues OxyContin maker Purdue Pharma

New York state sued Purdue Pharma LP, accusing the OxyContin maker of widespread fraud and deception in the marketing of opioids, and contributing to a nationwide epidemic.

Read More »

Acorda Therapeutics CTO Leaves To Helm Unnamed Biotech Company

Chief Technology Officer Rick Batycky is leaving Acorda Therapeutics to take over the helm of an unnamed biotechnology company.

Read More »

Novartis Nabs Siemens Veteran As New Head Of Ethics

As Novartis wrangles with the fallout from the Swiss drugmaker’s association with Michael Cohen and the fees it paid his consulting company for access to the administration of President Donald Trump, the Swiss pharma giant brought on a new chief ethics officer.

Read More »

Bayer teams up with Evotec, Haplogen

Collaboration partners Evotec AG and Haplogen GmbH announced that Haplogen will enter into a multi-year drug discovery and development deal with Bayer AG to focus on pulmonary diseases.

Read More »

Outcome Health Announces Partnership with American Liver Foundation to Promote Updated Screening Recommendations for Hepatitis C

Outcome Health announced a partnership with the American Liver Foundation to raise awareness of liver disease, specifically hepatitis C.

Read More »

Mustang Bio and St. Jude Children’s Research agree to develop gene therapy

Mustang Bio Inc. and St. Jude Children’s Research Hospital announced that they have partnered and entered into an exclusive worldwide license agreement for the development of a first-in-class ex vivo lentiviral gene therapy for the treatment of X-linked severe combined immunodeficiency (“X-SCID”), also known as bubble boy disease.

Read More »

Magnolia Neurosciences Launches with $31 Million

Magnolia Neurosciences, co-founded by Accelerator Life Science Partners and The University of Texas MD Anderson Cancer Center, launched with a $31 million Series A financing.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom